LanssonPharm
Suzhou
About LanssonPharm
LanssonPharm is a developer of innovative pharmaceutical products for neuropsychiatric diseases. They offer drugs that specifically target neurodegenerative diseases such as senile dementia, Parkinson's, schizophrenia, stroke, and other diseases of the central nervous system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $3.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2019)
- Website: lanssonpharm.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/lanssonpharm-87112 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.